Introduction to Buprenorphine Prescribing in Primary Care
This in-person event covers the essentials for providers to offer Buprenorphine to patients affected by Opioid Use Disorder
Registration in advance is required:
https://www.eventbrite.com/e/introduction-to-buprenorphine-prescribing-…
LOCATION: In-Person at the Hunting Park Location of Esperanza Health Center
4417 N 6th St, Philadelphia, PA 19140
Note: Space is limited to 15 Participants
TARGET AUDIENCE: Physicians, Physician Assistants, and Nurse Practitioners who have prescriptive authority.
CE's: Program eligible for CME's
LEARNING OBJECTIVES:
- Review Philadelphia specific epidemiology and the rationale for treating patients for opioid use disorder in primary care.
- Describe foundational concepts and approaches to safely prescribing and treating opioid use disorder in primary care settings.
- Describe principles of harm reduction as they relate to primary care practice.
- Describe practices related to prescribing Brixadi and Sublocade (Long Acting Injectable Buprenorphine).
PROGRAM AGENDA:
8:30 AM - 2:00 PM - includes light breakfast and lunch
Local Opioid Use Disorder Epidemiological Overview & Philadelphia Department of Public Health Initiatives
Presenter: Maya Puleo, MPH, Substance Use Epidemiologist, Division of Substance Use Prevention and Harm Reduction, Philadelphia Department of Public Health
Primer for Safely Prescribing Buprenorphine in Primary Care Settings
Presenter: Devora Keller, MD, MPH, Director of Clinical and Quality Improvement, National Healthcare for the Homeless Council
Incorporating Harm Reduction into Primary Care
Presenters: Rachael Truchil, MD, MPH, Associate Professor of Clinical Medicine, Perelman School of Medicine, University of Pennsylvania and Nicole O’Donnell, CRS, Program Manager, CareConnect Warmline, Center for Addiction Medicine and Policy, University of Pennsylvania
Starting Long Acting Injectable Buprenorphine: Site Preparation, Patient Selection, and Troubleshooting
Presenters: Kara M. Cohen, CRNP, Associate Director of Street Medicine, Project HOME Health Care Services and Rachael Truchil, MD, MPH, Associate Professor of Clinical Medicine, Perelman School of Medicine, University of Pennsylvania
FUNDING ACKNOWLEDGEMENT: The programs of SURGE are supported by SUPHR - the Substance Use Prevention and Harm Reduction Division of Philadelphia Department of Public Health, which leads the City's efforts to reduce deaths from drug overdose and improve access to help.